A Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Moderate to Severe Plaque Psoriasis

NCT06066125 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

351

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis
Skin Diseases

Interventions

DRUG: AK111
DRUG: AK111
DRUG: Placebo

Sponsor

Akeso